Wang Y, Shen Y, Tan L, Hu L, He M, Zeng X
Front Cardiovasc Med. 2024; 11:1404284.
PMID: 39421157
PMC: 11484250.
DOI: 10.3389/fcvm.2024.1404284.
Kim S, Lee J, Jeong W, Lee J, Kim Y
J Korean Med Sci. 2024; 39(4):e42.
PMID: 38288542
PMC: 10825460.
DOI: 10.3346/jkms.2024.39.e42.
Shin H, Jeon E, Lim B
Int J Mol Sci. 2023; 24(6).
PMID: 36982385
PMC: 10049483.
DOI: 10.3390/ijms24065309.
Mohamud Y, Li B, Bahreyni A, Luo H
Viruses. 2023; 15(2).
PMID: 36851568
PMC: 9963085.
DOI: 10.3390/v15020351.
Kim S, Shin H, Kim J, Park J, Jeon E, Lim B
Int J Mol Sci. 2022; 23(3).
PMID: 35163412
PMC: 8836114.
DOI: 10.3390/ijms23031489.
Immune Cells and Immunotherapy for Cardiac Injury and Repair.
Rurik J, Aghajanian H, Epstein J
Circ Res. 2021; 128(11):1766-1779.
PMID: 34043424
PMC: 8171813.
DOI: 10.1161/CIRCRESAHA.121.318005.
Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun S, Shin H, Ju E, Lee Y, Lim B, Jeon E
Int J Mol Sci. 2020; 21(9).
PMID: 32344926
PMC: 7246926.
DOI: 10.3390/ijms21093041.
Specific elimination of coxsackievirus B3 infected cells with a protein engineered toxin-antitoxin system.
Park J, Park J, Choi W, Lim B
Mol Cell Toxicol. 2020; 15(4):425-430.
PMID: 32226459
PMC: 7097453.
DOI: 10.1007/s13273-019-0046-4.
Immunosuppressive Treatment for Myocarditis in the Pediatric Population: A Meta-Analysis.
He B, Li X, Li D
Front Pediatr. 2019; 7:430.
PMID: 31803693
PMC: 6873897.
DOI: 10.3389/fped.2019.00430.
Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.
Zhao L, Fu Z
J Immunol Res. 2018; 2018:5301548.
PMID: 29854842
PMC: 5964556.
DOI: 10.1155/2018/5301548.
c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
Buskiewicz I, Koenig A, Roberts B, Russell J, Shi C, Lee S
PLoS One. 2014; 9(5):e96156.
PMID: 24816846
PMC: 4015977.
DOI: 10.1371/journal.pone.0096156.
Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.
Hanschmann E, Godoy J, Berndt C, Hudemann C, Lillig C
Antioxid Redox Signal. 2013; 19(13):1539-605.
PMID: 23397885
PMC: 3797455.
DOI: 10.1089/ars.2012.4599.
Diagnosis and treatment of viral myocarditis.
Schultz J, Hilliard A, Cooper Jr L, Rihal C
Mayo Clin Proc. 2009; 84(11):1001-9.
PMID: 19880690
PMC: 2770911.
DOI: 10.1016/S0025-6196(11)60670-8.
Amyocarditic coxsackievirus B3 causes myocarditis in immunocompromised mice.
Takada H, Kishimoto C, Kurokawa M, Hiraoka Y
Exp Clin Cardiol. 2009; 8(2):71-5.
PMID: 19641653
PMC: 2716202.
Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy.
Luo H, Wong J, Wong B
Cardiovasc Res. 2009; 85(2):347-56.
PMID: 19578074
PMC: 7109953.
DOI: 10.1093/cvr/cvp225.
Proteasome inhibition attenuates coxsackievirus-induced myocardial damage in mice.
Gao G, Zhang J, Si X, Wong J, Cheung C, McManus B
Am J Physiol Heart Circ Physiol. 2008; 295(1):H401-8.
PMID: 18515649
PMC: 2494750.
DOI: 10.1152/ajpheart.00292.2008.
Coxsackievirus B3 infection induces cyr61 activation via JNK to mediate cell death.
Kim S, Park J, Chung S, Kim J, Hwang H, Chung K
J Virol. 2004; 78(24):13479-88.
PMID: 15564459
PMC: 533934.
DOI: 10.1128/JVI.78.24.13479-13488.2004.
Coxsackievirus B3 infection and its mutation in Keshan disease.
Ren L, Li X, Li G, Zhao Z, Sun B, Sun F
World J Gastroenterol. 2004; 10(22):3299-302.
PMID: 15484304
PMC: 4572299.
DOI: 10.3748/wjg.v10.i22.3299.
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.
DeBiasi R, Robinson B, Sherry B, Bouchard R, Brown R, Rizeq M
J Virol. 2004; 78(20):11040-50.
PMID: 15452224
PMC: 521817.
DOI: 10.1128/JVI.78.20.11040-11050.2004.
Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy.
Gagliardi M, Bevilacqua M, Bassano C, Leonardi B, Boldrini R, Diomedi Camassei F
Heart. 2004; 90(10):1167-71.
PMID: 15367516
PMC: 1768474.
DOI: 10.1136/hrt.2003.026641.
